Latest News and Press Releases
Want to stay updated on the latest news?
-
Indianapolis, IN, March 10, 2026 (GLOBE NEWSWIRE) -- SpecSync, an intelligent configuration and quoting platform for complex manufacturing, launched today at the Work Truck Week conference,...
-
Worldwide rights position Erasca to advance ERAS-0015 through a unified global development strategy ERAS-0015’s promising early clinical data underscore its potential to be a best-in-class...
-
BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Zapata Quantum (OTC: ZPTA) (“Zapata”, “Zapata Quantum” or the “Company”), a pioneer in quantum computing application and algorithm development, today...
-
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31,...
-
MAA submission to the European Medicines Agency represents a key regulatory milestone in LENZ’s strategy to expand global access to VIZZ Submission of MAA in Europe results in the fifth ex-U.S....
-
BreachRx debuts industry-first CIRM Warranty, offering up to $3M in executive and corporate cyber incident liability protection backed by a global insurer.
-
SCOTTSDALE, AZ, March 10, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), today announced that the closing of its previously announced...
-
Post hoc analyses of two Phase 2 trials examine the potential benefits of solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, across Parkinson’s disease populationsPhase 2 adjunctive...
-
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. ("Terra Innovatum" or the “Company”) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors, announced it will release...
-
CARMEL, Ind., March 10, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...